Trial Profile
A double-blind, placebo-controlled evaluation of safety and efficacy of epicutaneously applied IDEA-033 (ketoprofen in transfersome) in comparison to oral celecoxib for the treatment of pain associated with osteoarthritis of the knee.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2009
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary) ; Celecoxib
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 24 Mar 2009 IDEA added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 22 Nov 2006 New trial record.